PROGEN — Prostatype Genomics AB Share News
0.000.00%
Last trade - 00:00- SEK27.88m
- SEK24.11m
- SEK0.59m
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants
Brief: Prostatype Genomics Starts Billing For Prostatype To Insurance Companies In US
Brief: Prostatype Genomics Resolves On Directed Issue Of Units
Brief: Prostatype To Get Around SEK 27.3 Mln From Rights Issue
Brief: Prostatype Genomics Resolves Rights Issue Of SEK 27.3 Mln
Brief: Prostatype Genomics Says Potential U.S. Tariffs Have Minimal Effect On Co Operations In U.S.
Brief: Prostatype Genomics H2 EBITDA Loss Widens To SEK 20.44 Mln
Brief: Prostatype Genomics Announces Directed Share Issue To Guarantors In Exercise Of TO 4 Warrants
Brief: Prostatype Genomics Wins SEK 1.3 Mln Order In Italy
Brief: Prostatype Genomics Obtains IVDR Certification
Brief: Prostatype Genomics Presents Business Plan For US Market
Brief: Prostatype Genomics Submits Medicare Reimbursement Application In U.S. Market For Gene Test Prostatype
Brief: Prostatype Genomic's Bod Proposes Reverse Share Split
Brief: Prostatype Genomics Decides On Directed Issue To Guarantors
Brief: Prostatype Genomics Rights Issue Closes with 79.8% Subscription
Brief: Prostatype Publishes Update On Commercial Progress In Spain